OncoMatch/Clinical Trials/NCT04214990
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Is NCT04214990 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies Aspirin 100mg for aspirin.
Treatment: Aspirin 100mg — This study aimed to investigate the effect of low-dose (100 mg) asprin on the prevention of gastric cancer in the early gastric cancer patients with negative H. pylori status who underwent endoscopic submucosal dissection.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Gastric Cancer
Disease stage
Required: Stage CATEGORY 4, CATEGORY 5 (Vienna classification of gastrointestinal epithelial neoplasia)
Grade: high-grade (Vienna classification)
category 4 [non-invasive high grade neoplasm] or category 5 [invasive neoplasia] according to the Vienna classification
Demographics
Prior therapy
Must have received: endoscopic resection
who underwent endoscopic resection for high-grade adenoma or early gastric cancer
Cannot have received: gastrectomy
Previous gastrectomy history
Cannot have received: aspirin (secondary prevention of cardiovascular/cerebrovascular disease)
Patients who received aspirin for the secondary prevention of cardiovascular diseases or cerebrovascular diseases
Cannot have received: regular aspirin use
Regular aspirin uses (more than 3 times a week) with 2 months before screening visit
Cannot have received: anticoagulant or antiplatelet drugs
Patients who used anticoagulants or antiplatelet drugs for therapeutic purpose
Cannot have received: non-curative resection
Non-curative resection of early gastric cancer after endoscopic resection
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT04214990 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior gastrectomy, aspirin (secondary prevention of cardiovascular/cerebrovascular disease), regular aspirin use disqualifies patients from enrollment.
What disease stage is eligible?
Stage CATEGORY 4 or CATEGORY 5 is required.
Is there an age limit?
Yes. Patients must be 70 years or younger and at least 19 years old.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages